Cargando…

Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection

BACKGROUND: To look at the differences and similarities in albumin and lipid metabolism in non-severe COVID-19 infection, non-severe community-acquired pneumonia, and severe community pneumonia with underlying diseases, as well as the relationship between albumin and lipid metabolism and inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zheng, Wang, Qian, Wang, Hui, Li, Jing, Yuan, Ying, Yi, Guo-zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024871/
https://www.ncbi.nlm.nih.gov/pubmed/36945318
http://dx.doi.org/10.2147/JIR.S399921
_version_ 1784909203502006272
author Liu, Zheng
Wang, Qian
Wang, Hui
Li, Jing
Yuan, Ying
Yi, Guo-zhen
author_facet Liu, Zheng
Wang, Qian
Wang, Hui
Li, Jing
Yuan, Ying
Yi, Guo-zhen
author_sort Liu, Zheng
collection PubMed
description BACKGROUND: To look at the differences and similarities in albumin and lipid metabolism in non-severe COVID-19 infection, non-severe community-acquired pneumonia, and severe community pneumonia with underlying diseases, as well as the relationship between albumin and lipid metabolism and inflammatory mediators. METHODS: This retrospective analysis comprised 253 individuals with bacterial pneumonia and COVID-19 infection (1 May 2021–1 May 2022). Routine blood examination, blood lipid levels, albumin level, C-reactive protein (CRP) levels, coagulation function, cardiac enzymes, liver function, renal function, immunological function, and bacterial culture were also collected. Correlation analysis was performed using Spearman's test for lipid parameter and Inflammatory factors in the blood. Furthermore, the multiple linear regression (MLR) analysis was employed to analyze the multicollinearity in lipidomics data. The statistical analysis was performed using SPSS statistic version 19.0. RESULTS: There were 63 (24.90%) non-severe community-acquired pneumonia patients (NSCAP), 48 (18.97%) severe community-acquired pneumonia patients (SCAP), 112 (44.27%) non-severe COVID-19 infection patients (NSCOV), and 30 (11.86%) healthy volunteers (HV). In all, 45.59% (116/253) of the patients had underlying diseases. Patients with community-acquired pneumonia had lower albumin and cholesterol levels than those with non-severe COVID-19 infection and healthy controls (t = −3.81, −2.09, P = 0.00, 0.04). Albumin, triglyceride, cholesterol, and LDL-C levels in peripheral blood were considerably lower in the SCAP group than in the NSCAP group. Albumin, cholesterol, HDL-C, LDL-C, and aop-A were all inversely connected with CRP in the SCAP with underlying illness group, but cholesterol level was favorably correlated with lymphocyte count (R = 0.36, P = 0.01). Hypoproteinemia, hypotriglyceridemia, and an elevated neutrophil-to-lymphocyte count ratio are all risk factors for severe community-acquired pneumonia. CONCLUSION: Hypoalbuminemia and abnormal lipid metabolism are important indicators of bacterial infection, especially severe bacterial pneumonia.
format Online
Article
Text
id pubmed-10024871
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100248712023-03-20 Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection Liu, Zheng Wang, Qian Wang, Hui Li, Jing Yuan, Ying Yi, Guo-zhen J Inflamm Res Original Research BACKGROUND: To look at the differences and similarities in albumin and lipid metabolism in non-severe COVID-19 infection, non-severe community-acquired pneumonia, and severe community pneumonia with underlying diseases, as well as the relationship between albumin and lipid metabolism and inflammatory mediators. METHODS: This retrospective analysis comprised 253 individuals with bacterial pneumonia and COVID-19 infection (1 May 2021–1 May 2022). Routine blood examination, blood lipid levels, albumin level, C-reactive protein (CRP) levels, coagulation function, cardiac enzymes, liver function, renal function, immunological function, and bacterial culture were also collected. Correlation analysis was performed using Spearman's test for lipid parameter and Inflammatory factors in the blood. Furthermore, the multiple linear regression (MLR) analysis was employed to analyze the multicollinearity in lipidomics data. The statistical analysis was performed using SPSS statistic version 19.0. RESULTS: There were 63 (24.90%) non-severe community-acquired pneumonia patients (NSCAP), 48 (18.97%) severe community-acquired pneumonia patients (SCAP), 112 (44.27%) non-severe COVID-19 infection patients (NSCOV), and 30 (11.86%) healthy volunteers (HV). In all, 45.59% (116/253) of the patients had underlying diseases. Patients with community-acquired pneumonia had lower albumin and cholesterol levels than those with non-severe COVID-19 infection and healthy controls (t = −3.81, −2.09, P = 0.00, 0.04). Albumin, triglyceride, cholesterol, and LDL-C levels in peripheral blood were considerably lower in the SCAP group than in the NSCAP group. Albumin, cholesterol, HDL-C, LDL-C, and aop-A were all inversely connected with CRP in the SCAP with underlying illness group, but cholesterol level was favorably correlated with lymphocyte count (R = 0.36, P = 0.01). Hypoproteinemia, hypotriglyceridemia, and an elevated neutrophil-to-lymphocyte count ratio are all risk factors for severe community-acquired pneumonia. CONCLUSION: Hypoalbuminemia and abnormal lipid metabolism are important indicators of bacterial infection, especially severe bacterial pneumonia. Dove 2023-03-15 /pmc/articles/PMC10024871/ /pubmed/36945318 http://dx.doi.org/10.2147/JIR.S399921 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Zheng
Wang, Qian
Wang, Hui
Li, Jing
Yuan, Ying
Yi, Guo-zhen
Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection
title Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection
title_full Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection
title_fullStr Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection
title_full_unstemmed Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection
title_short Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection
title_sort biomarkers for lipid and albumin metabolism in hospitalized patients with underlying diseases and community-acquired pneumonia caused by bacterial or sars-cov-2 infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024871/
https://www.ncbi.nlm.nih.gov/pubmed/36945318
http://dx.doi.org/10.2147/JIR.S399921
work_keys_str_mv AT liuzheng biomarkersforlipidandalbuminmetabolisminhospitalizedpatientswithunderlyingdiseasesandcommunityacquiredpneumoniacausedbybacterialorsarscov2infection
AT wangqian biomarkersforlipidandalbuminmetabolisminhospitalizedpatientswithunderlyingdiseasesandcommunityacquiredpneumoniacausedbybacterialorsarscov2infection
AT wanghui biomarkersforlipidandalbuminmetabolisminhospitalizedpatientswithunderlyingdiseasesandcommunityacquiredpneumoniacausedbybacterialorsarscov2infection
AT lijing biomarkersforlipidandalbuminmetabolisminhospitalizedpatientswithunderlyingdiseasesandcommunityacquiredpneumoniacausedbybacterialorsarscov2infection
AT yuanying biomarkersforlipidandalbuminmetabolisminhospitalizedpatientswithunderlyingdiseasesandcommunityacquiredpneumoniacausedbybacterialorsarscov2infection
AT yiguozhen biomarkersforlipidandalbuminmetabolisminhospitalizedpatientswithunderlyingdiseasesandcommunityacquiredpneumoniacausedbybacterialorsarscov2infection